Hepatitis Australia monitors for news articles which have relevance to hepatitis B or hepatitis C in Australia. From time-to-time we also issue public statements and media releases which will also be shared here.
The purpose of this brief is to provide the viral hepatitis community and sector workforce with an update on telehealth for hepatitis B and hepatitis C. Read more
Hepatitis Australia is seeking an evaluation expert to develop a Monitoring and Evaluation Framework for ongoing implementation by the organisation. Read more
Hepatitis Australia is seeking applications from a person interested in joining the Hepatitis Australia Board as a Community Board Member to be appointed at the 2021 Annual General Meeting for a two-year term. Read more
Hepatitis Australia is seeking a highly skilled policy and research analyst with a commitment to social justice and public health. Read more
For World Hepatitis Day 2021 Australia adopted the global theme of Hep Can’t Wait! In this article we highlight some of the activities that took place in Australia and through our global partners. Read more
In the lead up to World Hepatitis Day on 28 July, Hepatitis Australia is collaborating with many other Australian organisations, research institutes and professional bodies to provide invaluable insights into hepatitis B and hepatitis C in Australia. Find out how you can help. Read more
The Parliamentary Friends Group for Action of Blood Borne Viruses Co-Chairs, Tim Wilson, MP and Senator Louise Pratt invite you to a Parliamentary Morning Tea on Thursday 12 November. Read more
The Australian Injecting and Illicit Drug Users League (AIVL) and Hepatitis Australia are highlighting international calls for Needle and Syringe Programs (NSPs) in prisons, along with a greater focus on harm reduction initiatives, ahead of International Drug Users Day on 1 November. Read more
6 October 2020 - Hepatitis Australia welcomes the Australian Government’s commitment to diverse hepatitis research, however we remain concerned that the 2019 Health Budget funding for hepatitis commitments is yet to hit the ground. Read more
6 October 2020 - Hepatitis Australia welcomes the Australian Government’s significant investment of $230 million to expand the listing of Tecentriq® and Avastin® (atezolizumab and bevacizumab) on the Pharmaceutical Benefits Scheme (PBS). Read more
6 October 2020 - Hepatitis Australia is celebrating the news that the Nobel Prize in Physiology or Medicine 2020 has been awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice ‘for the discovery of Hepatitis C virus’. Read more
Patient safety and continuity of care is extremely important, particularly for people who have chronic and complex diseases or conditions, which is why Hepatitis Australia has joined the Continuity of Care Collaboration Read more
22 September 2020: Hepatology Nurse Practitioner, Tracey Jones, has become the first Australian nurse to be awarded the Associate Fellow designation from the American Association for the Study of Liver Diseases Read more
As Australia grapples with COVID-19 outbreaks, it is important to remember that viral hepatitis is also a pandemic. Viral hepatitis can lead to liver cancer and directly impacts nearly 360,000 people in Australia. Read more
24 July 2020 - Australia’s leading drug and infectious disease organisations will join forces to call for a re-engagement in elimination of hepatitis C in an online event on World Hepatitis Day, Tuesday, 28 July 2020. Read more
23 July 2020 - Except from article from ABC Far North about hepatitis C outbreak in Queensland correctional centre. Read more
Recent changes to the Pharmaceutical Benefits Scheme (PBS) allows authorised Nurse Practitioners to prescribe hepatitis B and hepatitis C medicines under the Highly Specialised Drugs (s100) Program. Read more
Hepatitis Australia has put together a brief factsheet with information about the coronavirus COVID-19 for people living with hepatitis B and hepatitis C. Read more
04 March 2020 - Hepatitis Australia announces appointment of new CEO Read more
The Pharmaceutical Benefits Advisory Committee will consider loosening the prescribing authority for PBS-listed hepatitis C medicines but the real focus seems to be on securing a price reduction. Read more
17 January 2020 - Hepatitis Australia announces Grant Phelps as the new President of the Board. Read more
14 November 2019: Leaders of liver disease associations from Europe, the United States, Latin America and Asia issued a global call to action at AASLD, aiming to advance toward the goal of eliminating hepatitis C as a public health threat. Read more
4 November 2019: Praise for the CEO of Hepatitis Australia Helen Tyrrell who has announced her intention to retire from the organisation she has led since 2005 Read more
4 November 2019: OTTAWA; Setting up supervised injection sites at federal institutions is the way to go says the Union of Canadian Correctional Officers. Read more